Research Study of T Cell Immunotherapy Continues to Show Highly Promising Results in Children and Ad
- OPACC
- Dec 13, 2013
- 1 min read
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient's immune system.
Comentarios